Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM5C | P41229 | 1/20 | 0.49 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.49 |
| ▸ | KDM3A | Q9Y4C1 | 1/20 | 0.49 |
| ▸ | GPR119 | Q8TDV5 | 10/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
| ▸ | RORC | P51449 | 1/20 | 0.44 |
| ▸ | TP53 | P04637 | 2/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | PKM | P14618 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 2/20 | 0.43 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.42 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27153477 | 0.85 | KDM5C (0.51) | KDM5CKDM2AKDM3AALDH1A1LMNA | |
| SCHEMBL14692527 | 0.85 | GPR119 (0.46) | KDM5CKDM2AKDM3AGPR119KDM4E | |
| SCHEMBL20967258 | 0.84 | GPR119 (0.47) | GPR119KDM4EDDB1CRBN | |
| SCHEMBL23911654 | 0.83 | KDM4E (0.47) | KDM5CKDM2AKDM3AGPR119KMT2A | |
| SCHEMBL17591926 | 0.83 | ALDH1A1 (0.50) | KDM5CKDM2AKDM3AALDH1A1MEN1 | |
| SCHEMBL14635882 | 0.82 | GPR119 (0.48) | GPR119ALDH1A1MEN1LMNAGAA | |
| SCHEMBL18376153 | 0.82 | GPR119 (0.47) | KDM5CKDM2AKDM3AGPR119TP53 | |
| SCHEMBL1336511 | 0.80 | GPR119 (0.52) | GPR119ALDH1A1MEN1LMNAGAA | |
| SCHEMBL15393709 | 0.80 | ALDH1A1 (0.38) | GPR119ALDH1A1MEN1LMNAGAA | |
| SCHEMBL22730298 | 0.80 | ALDH1A1 (0.45) | KDM5CKDM2AKDM3AGPR119ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260069580-A1 | PEROXIREDOXIN 3 INHIBITORS AND METHODS OF USE FOR TREATING CANCER | UNIV WAKE FOREST HEALTH SCIENCES (US) | 2026-03-12 | — | — | US | disclosed |
| WO-2024044748-A2 | PEROXIREDOXIN 3 INHIBITORS AND METHODS OF USE FOR TREATING CANCER | WAKE FOREST UNIVERSITY HEALTH SCIENCES (US) | 2024-02-29 | — | — | WO | disclosed |
| US-20210317113-A1 | 1,2,3-TRIAZOLE DERIVATIVES AND USES THEREOF | Alxerion Biotech LLC | 2021-10-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210317113-A1 | 1,2,3-TRIAZOLE DERIVATIVES AND USES THEREOF | CYP3A43, CYP51A1, CYP11B2 | KDM5C 2848/4885KDM2A 3692/4885KDM3A 673/4885 |
| US-20260069580-A1 | PEROXIREDOXIN 3 INHIBITORS AND METHODS OF USE FOR TREATING CANCER | PRDX3, PRDX1, PRDX5 | KDM5C 1776/4885KDM2A 2683/4885KDM3A 677/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.